Telesis Bio, Inc. - Common Stock
Telesis Bio, Inc. - Common Stock
Action · US1920031010 · TBIO (XNAS)
Aperçu
Pas de cours
14.10.2025 18:45
1 jour
-
1 semaine
-
1 mois
-
3 mois
-
6 mois
-
Année à ce jour
-
1 an
-
2 ans
-
3 ans
-
4 ans
-
5 ans
-
10 ans
-
20 ans
-
Max
-
Résumé de la Note des Analystes
gauge-img
Achat
Achat fort
Achat
Conserver
Vente
Vente forte
0
3
0
0
0
Cours actuels de Telesis Bio, Inc. - Common Stock
BourseTickerDeviseDernier échangeCoursVariation journalière
XNAS: NASDAQ
NASDAQ
TBIO
USD
14.10.2025 18:45
0,01 USD
-0,0004 USD
-3,90 %
Flottant et Liquidité des Actions
Flottant Libre 25,55 %
Actions en Flottant 7,53 M
Actions en Circulation 29,48 M
Profil de l'entreprise pour Telesis Bio, Inc. - Common Stock Action
Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA; BioXp portal, an online portal that offers an intuitive guided workflow and design tools for building new DNA sequences and assembling them into vectors of choice; BioXp kits that contain building blocks and reagents, including its Gibson Assembly branded reagents, for specific synthetic biology workflow applications; Cloud-based scripts; Benchtop reagents that contain all the reagents necessary to proceed with a specific synthetic biology workflow on the benchtop using products generated on the BioXp system; Biofoundry Services, which enable a customer to order and receive the BioXp system endpoint-ready products, such as genes, clones, cell-free amplified DNA, and variant libraries; and short oligo ligation assembly enzymatic DNA synthesis. It also serves government institutions, contract research organizations, and synthetic biology companies. The company was formerly known as SGI-DNA, Inc. and changed its name to Codex DNA, Inc. in March 2020. Codex DNA, Inc. was incorporated in 2011 and is headquartered in San Diego, California.

Données de l'entreprise

Nom Telesis Bio, Inc. - Common Stock
Société Codex DNA, Inc.
Symbole TBIO
Site web https://codexdna.com
Marché d'origine XNAS NASDAQ
ISIN US1920031010
Type de titre Action
Secteur Healthcare
Industrie Medical - Devices
PDG Todd R. Nelson MBA,
Capitalisation boursière 38 Mio
Pays États-Unis d'Amérique
Devise USD
Employés 0,2 T
Adresse 9535 Waples Street, 92121-2993 San Diego
Date d'introduction en bourse 2021-06-18

Changements d'identifiant

Date De À
04.01.2023 DNAY TBIO

Symboles boursiers

Nom Symbole
NASDAQ DNAY
NASDAQ TBIO
Autres actions
Les investisseurs qui détiennent Telesis Bio, Inc. - Common Stock ont également les actions suivantes dans leur portefeuille :
CM.HOME LOAN 23/27 MTN
CM.HOME LOAN 23/27 MTN Obligation
COTY INC. 23/28 REGS
COTY INC. 23/28 REGS Obligation
La plateforme financière MoneyPeak suit et analyse les investissements et les portefeuilles. Du dépôt de titres à l'achat de crypto.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.
Mentions légales Protection des données Blog Communauté Retour d'information Changelog
Im App Store herunterladen Bei Google Play herunterladen
Tous droits réservés © LCP GmbH 2025